Loading candles…
Zim Laboratories Ltd, incorporated in 1989 and headquartered in India, operates in the pharmaceutical and nutraceutical industries. The company manufactures formulation drugs and pre-formulation ingredients, focusing on differentiated and complex generic products. Its offerings include oral solid dosage forms, Novel Drug Delivery Systems (NDDS), Pre-Formulation Intermediates (PFI), and Finished Formulations (FF). Zim Laboratories markets and sells its products both within India and internationally, covering regulated, pharmerging, and other global markets. The company emphasizes development and manufacturing using proprietary technologies to serve the pharmaceutical and nutraceutical sectors.
| Results - FY25 |
| To consider and approve the financial results for the period ended December 31, 2025 |
| 11 Feb 2026 |
| Fund Raising | To consider Fund Raising | 21 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 12 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 7 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 20 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.